Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Anavex Life Sciences (AVXL)
NASDAQ:AVXL
RESEARCH TOOLSreports
Holding AVXL?
Track your performance easily
Anavex Life Sciences (AVXL) Ownership Overview
3.05% Insiders
8.24% Mutual Funds
0.48% Other Institutional Investors
12.84% ETFs
75.38% Public Companies and Individual Investors
The ownership structure of Anavex Life Sciences (AVXL) stock is a mix of institutional, retail, and individual investors. Approximately 21.56% of the company’s stock is owned by Institutional Investors, 3.05% is owned by Insiders, and 75.38% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 17, 2024 | Peter D.o. Donhauser Director | xxxxxxxxxxxxx | $10319 |
| May 17, 2024 | Thomas Steffen Director | xxxxxxxxxxxxx | $22600 |
| Apr 01, 2024 | Christopher Missling President & Ceo,director | xxxxxxxxxxxxx | $374972 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $64355 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $345575 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,553,156 | Institution | 5.37% | 42,071,161 | |
| 3,857,740 | Institution | 4.55% | 35,645,518 | |
| 3,757,018 | Institution | 4.43% | 34,714,846 | |
| 1,607,352 | Institution | 1.90% | 14,851,932 | |
| 1,306,458 | Insider | 1.54% | 12,071,672 | |
| 1,250,210 | Insider | 1.47% | 11,551,940 | |
| 898,754 | Institution | 1.06% | 8,304,487 | |
| 812,054 | Institution | 0.96% | 7,503,379 | |
| 454,859 | Institution | 0.54% | 4,202,897 | |
| 356,937 | Institution | 0.42% | 3,298,098 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,757,018 | Institution | 4.43% | 34,714,846 | |
| 898,754 | Institution | 1.06% | 8,304,487 | |
| 812,054 | Institution | 0.96% | 7,503,379 | |
| 356,937 | Institution | 0.42% | 3,298,098 | |
| 287,880 | Institution | 0.34% | 2,660,011 | |
| 274,894 | Institution | 0.32% | 2,540,021 | |
| 211,842 | Institution | 0.25% | 1,957,420 | |
| 55,577 | Institution | 0.07% | 513,531 | |
| 44,887 | Institution | 0.05% | 414,756 | |
| 30,386 | Institution | 0.04% | 280,767 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,056,971 | Institution | 2.43% | 19,006,412 | |
| 2,534,500 | Institution | 2.99% | 14,395,960 | |
| 1,573,971 | Institution | 1.86% | 12,017,269 | |
| 1,331,600 | Institution | 1.57% | 7,563,488 | |
| 581,949 | Institution | 0.69% | 5,377,209 | |
| 530,037 | Institution | 0.63% | 4,897,542 | |
| 407,249 | Institution | 0.48% | 3,109,346 | |
| 344,200 | Institution | 0.41% | 1,955,056 | |
| 188,793 | Institution | 0.22% | 1,744,447 | |
| 282,570 | Institution | 0.33% | 1,604,998 |
FAQ
Who Owns Anavex Life Sciences (AVXL)?
According to the latest TipRanks data, approximately 0.48% of the company's stock is held by institutional investors, 3.05% is held by insiders, and 75.38% is held by retail investors.
What percentage of Anavex Life Sciences (AVXL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.48% of Anavex Life Sciences (AVXL) stock is held by institutional investors.
What percentage of Anavex Life Sciences (AVXL) stock is held by retail investors?
According to the latest TipRanks data, approximately 75.38% of Anavex Life Sciences (AVXL) stock is held by retail investors.
Who owns the most shares of Anavex Life Sciences (AVXL)?
Vanguard owns the most shares of Anavex Life Sciences (AVXL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.